STERIS (STE) Could Be 16% Undervalued If Its Recurring Revenue Story Holds

Simply Wall St.06-28

AdvertisementRecent Performance Snapshot for STERIS Stock STERIS (STE) has drawn investor attention after a period where short term and longer term returns have moved in different directions, with the...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646157093?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2026-06-28 03:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646157093","market":"sg","top_or_hot":-1,"title":"STERIS (STE) Could Be 16% Undervalued If Its Recurring Revenue Story Holds","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementRecent Performance Snapshot for STERIS Stock STERIS (STE) has drawn investor attention after a period where short term and longer term returns have moved in different directions, with the...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ste/steris/news/steris-ste-could-be-16-undervalued-if-its-recurring-revenue\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>STERIS (STE) Could Be 16% Undervalued If Its Recurring Revenue Story Holds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSTERIS (STE) Could Be 16% Undervalued If Its Recurring Revenue Story Holds\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-28 03:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-ste/steris/news/steris-ste-could-be-16-undervalued-if-its-recurring-revenue><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementRecent Performance Snapshot for STERIS Stock STERIS (STE) has drawn investor attention after a period where short term and longer term returns have moved in different directions, with the...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ste/steris/news/steris-ste-could-be-16-undervalued-if-its-recurring-revenue\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STE","symbol_name":"思泰瑞医疗","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ste/steris/news/steris-ste-could-be-16-undervalued-if-its-recurring-revenue","article_id":"2646157093","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ste/steris/news/steris-ste-could-be-16-undervalued-if-its-recurring-revenue","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2646157093","pubTimestamp":1782587948,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recent Performance Snapshot for STERIS Stock\nSTERIS (STE) has drawn investor attention after a period where short term and longer term returns have moved in different directions, with the stock showing mixed performance across the past week, month and past 3 months.\nSee our latest analysis for STERIS.\nAt a share price of $215.67, STERIS has recently shown stronger short term momentum, with a 1 day share price return of 2.41% and 7 day share price return of 6.45%, while the year to date share...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"STE":"思泰瑞医疗"},"translate_title":"如果STERIS(STE)的经常性收入故事成立，其估值可能会被低估16%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STE":1.5},"content_text":"AdvertisementRecent Performance Snapshot for STERIS Stock STERIS (STE) has drawn investor attention after a period where short term and longer term returns have moved in different directions, with the stock showing mixed performance across the past week, month and past 3 months. See our latest analysis for STERIS. At a share price of $215.67, STERIS has recently shown stronger short term momentum, with a 1 day share price return of 2.41% and 7 day share price return of 6.45%, while the year to date share price return is down 13.75% and the 1 year total shareholder return is down 8.72%. This suggests recent optimism is emerging after a weaker period for holders. If STERIS has you reassessing where growth and resilience might come from next, it could be worth scanning for other healthcare technology opportunities through the 39 healthcare AI stocks With STERIS shares sitting at $215.67 and recent returns pulling in different directions, the key question is whether the current valuation still leaves a margin of safety or if the market is already pricing in future growth. Most Popular Narrative: 16% Undervalued Compared with STERIS's last close at $215.67, the most followed narrative places fair value at about $256.86, framing the current price as a discount that relies heavily on future earnings strength and recurring revenue.  Continued expansion of STERIS's consumables and services segments with high recurring revenue and margin visibility positions the company to benefit from increasing healthcare expenditures and adoption of best-practice infection control standards, supporting both revenue and margin expansion.  Read the complete narrative. Read the complete narrative. Curious what kind of revenue mix and profit margin profile could justify a higher fair value than today's price, while also assuming a richer future earnings multiple? The key assumptions blend steady top line growth, rising profitability and a projected valuation level above the broader medical equipment group, all filtered through a specific discount rate and share count path that shape the end result. Result: Fair Value of $256.86 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, STERIS still faces tariff exposure on key inputs and ongoing healthcare reimbursement and payment pressures, which could weigh on margins and temper the current upside narrative. Find out about the key risks to this STERIS narrative. Another View on STERIS Valuation While the analyst narrative points to STERIS as about 16% undervalued at a fair value of $256.86, the current P/E of 26.9x is higher than both the peer average of 21.9x and the US Medical Equipment industry at 25.7x, and above a fair ratio of 22.8x. This raises the question of how much optimism is already in the price. For a closer look at what this gap between the current P/E, peers, and the fair ratio might mean for valuation risk, see what the numbers say in our valuation breakdown through the See what the numbers say about this price — find out in our valuation breakdown. NYSE:STE P/E Ratio as at Jun 2026Next Steps With mixed signals on value and expectations circling STERIS, the real edge comes from checking the details yourself and deciding what truly matters for your portfolio. To weigh both the concerns and the potential upside in one place, take a closer look at the 3 key rewards and 1 important warning sign Looking for more investment ideas beyond STERIS? If STERIS has sharpened your focus on quality, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.  Zero in on potential bargains by scanning companies that combine quality fundamentals with attractive pricing through the 44 high quality undervalued stocks. Strengthen your income stream by reviewing companies that offer yield and resilience using the 8 dividend fortresses. Prioritise capital preservation by checking companies that score well on stability and financial risk through the 71 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646157093","isCrawlerRequest":true}